K Number
K023651
Manufacturer
Date Cleared
2004-02-17

(475 days)

Product Code
Regulation Number
882.4560
Reference & Predicate Devices
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

VectorVision Cranial/ENT is intended to be an intraoperative image guided localization system to enable minimally invasive surgery. It links a freehand probe, tracked by a passive market sensor system to virtual computer image space on patient image data being processed hy the VectorVision workstation.

The system is indicated for any medical condition in which the use of stereotactic surgery may be appropriate and where a reference to a rigid anatomical structure, such as the skill, a long bone, or vertebra, can be identified relative to a CT, CTA, X-ray, MR, MRA and ultrasound based model of the anatomy.

Example procedures include but are not limited to:

Cranial Procedures: Cranial biopsies Tumor resections Craniotomies/ Craniectomies Skull base procedures Thalamotomies/Pallidotomies

ENT Procedures: Transphenoidal procedures Intranasal procedures Sinus procedures, such as Maximillary antrostomies, Ethmoidectomies, Spheno-idotomies / Sphenoid explorations, Turbinate resections and Frontal sinusotomies

Device Description

The tracking system consists of two infrared light sources and infrared cameras. Around each camera lens is an array of infrared LED's, which flood the field of view with infrared light. The infrared light is reflected by retro-reflective material (reflects light back to the light source) to the two cameras. This tracking principle does not require electrical cords on the reflecting targets and is therefore called passive tracking system.

Software: The tracking system sends the targets 2D and 3D position to the navigation workstation, The navigation software uses this information considering known geometric information for tracking the 3D position of probes and other surgical tools with attached retro-reflective marker arrays. To link the virtual diagnostic image space within the navigation system to the surgical environment, the surgeon selects points on the patient using a tracked pointer probe. The selected points are stored and interpreted by the computer and related to corresponding points extracted from the diagnostic image data sets. A different option to register the patient anatomy to the virtual image space is provided by means of a laser scanning device. With this laser device the surface of the patients head is scanned meanwhile the IR camera system picks up the laser reflections on the patients skin. By creating a virtual surface model out of the 3D coordinates of these laser points the software matches patient data set and the patient position inside the operation poor. Another contactless registration method for MR image data is provided by a localizer geometry of MR markers, which is - by fixed relation to the patient and the reference array and by automatic registration of the markers - a direct link to the virtual inage space. In combination with the integration of data transfer functionalities this registration method is preferred for intra-operative MR data use. The device visualizes patient data including the option to overlay multiple data sets, outlined structures and trajectories. The area of interest is displayed in the virtual computer image space in 2D- and 3D-representations. For the localization of any area or structure in the patient's body a pointer tool is used or any other surgical instrument with attached retro-reflective marker arrays. A special device is available to precisely register any surgical instrument for navigation. Surgical microscopes are integrated similarly as a virtual pointer tool by a mounted marker array and a software interface. With image injection modules and video display a close cooperation of navigation system and microscope is achieved. Other intraoperative image sources like ultrasound transducers and endoscopes are tracked and integrated similarly and can be controlled within the software to be displayed on an external display device for the purpose of non-diagnostic image information overview. For sending requests and commands to external software and computers via network, e.q. for controlling the content of the external display device, a general communication interface is integrated into the navigation software.

Hardware: The VectorVision hardware platforms consist of electronic hardware combined in different housings which allow to adapt to the respective needs in certain OR settings. There are infrared cameras and a touch-screen, signal transmission cables, the navigation workstation itself and cable interfaces to external devices (e.g. microscopes). Currently there are 3 platforms available: VectorVision?, VectorVision Compact and VectorVision Sky. With the VectorVision Sky ceiling mounted articulated arms carry camera and touchscreen. The VectorVision Sky can be prepared for use in magnet-resonance environments with shielded RF cage e.g. by providing optical signal transmission. Interfacing external devices such as a microscope and/or a surgical endoscope is realized by interface elements in a wall panel box.

VectorVision does not contain implants but provides a system for accurate implant placement.

AI/ML Overview

Here's a summary of the acceptance criteria and the study details for the VectorVision Cranial/ENT device, based on the provided text:

Acceptance Criteria and Device Performance

The provided 510(k) summary does not explicitly state quantitative acceptance criteria or a specific table showing device performance against such criteria. Instead, it relies on the concept of "substantial equivalence" to predicate devices. The primary claim is that the device has been "verified and validated according to BrainLAB's procedures for product design and development," and this validation "proves the safety and effectiveness of the system." The FDA's final letter (page 4-5) confirms that the device is "substantially equivalent" to the predicate devices.

Therefore, the acceptance criterion implicitly is that the VectorVision Cranial/ENT device performs with similar safety and effectiveness to its predicate devices: VectorVision® 2 (K 983831) and VectorVision Cranial / ENT / Spine (K003589).

Study Details:

The provided document describes a submission for a 510(k) premarket notification, which largely relies on demonstrating substantial equivalence rather than presenting a detailed clinical study with specific performance metrics as commonly seen in PMAs or later-stage clinical trials.

  1. Sample size used for the test set and the data provenance:

    • The document does not specify a sample size for a test set. The validation mentioned is stated as being "according to BrainLAB's procedures for product design and development," which would typically involve internal testing and verification/validation activities. There's no mention of a specific patient-based test set or its provenance (country of origin, retrospective/prospective).
  2. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:

    • This information is not provided. The document focuses on the technical aspects of the device and its equivalence.
  3. Adjudication method for the test set:

    • This information is not provided.
  4. If a multi-reader, multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

    • No MRMC comparative effectiveness study is mentioned. This device is an image-guided surgery system, not an AI-based diagnostic tool that would typically involve human readers interpreting AI output. Its primary function is intraoperative localization and guidance rather than AI-assisted diagnosis.
  5. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done:

    • The document implies that the "validation proves the safety and effectiveness of the system." This likely refers to various engineering and system-level tests for accuracy, precision, and functionality of the tracking and visualization algorithms in a standalone manner (without a human actively using it in a clinical setting for performance metrics). However, specific metrics and a formal "standalone study" akin to an AI diagnostic device are not detailed. The system's purpose is inherently human-in-the-loop for surgical guidance.
  6. The type of ground truth used (expert consensus, pathology, outcomes data, etc.):

    • The document does not specify the type of ground truth used for performance evaluation. For an image-guided surgery system, ground truth would typically relate to the accuracy of probe localization relative to anatomical structures, which would be established through highly precise measurement techniques in controlled settings (e.g., phantom studies, cadaveric studies with known fiducials). It's not a diagnostic device where pathology or expert consensus on findings would be the primary ground truth.
  7. The sample size for the training set:

    • This information is not provided. The device described does not appear to be a machine learning or AI algorithm in the contemporary sense that would require a large "training set" to learn patterns. Its functionality is based on established optical tracking and image processing principles.
  8. How the ground truth for the training set was established:

    • As there is no mention of a "training set" in the context of an AI/ML algorithm, this information is not applicable and hence not provided.

{0}------------------------------------------------

K023651

510 (k) Summary of Safety and Effectiveness for VectorVision Cranial/ENT

Manufacturer:

Address:BrainLAB AGAmmerthalstrasse 885551 HeimstettenGermanyPhone: +49 89 99 15 68 0Fax: +49 89 99 15 68 33
Contact Person:Mr. Rainer Birkenbach
Summary Date:Nov 17, 2003
Device Name:
Trade name:VectorVision Cranial / ENT
Common/Classification Name:Image Guided Surgery System, CAS / Stereotaxy

Instrument

Predicate Device: Vector Vision® 2 (K 983831) VectorVision Cranial / ENT / Spine (K003589)

Device Classification Name: Stereotaxy Instrument Regulatory Class: Class II

Indications For Use:

VectorVision Cranial/ENT is intended to be an intraoperative image guided localization system to enable minimally invasive surgery. It links a freehand probe, tracked by a passive market sensor system to virtual computer image space on patient image data being processed hy the VectorVision workstation.

The system is indicated for any medical condition in which the use of stereotactic surgery may be appropriate and where a reference to a rigid anatomical structure, such as the skill, a long bone, or vertebra, can be identified relative to a CT, CTA, X-ray, MR, MRA and ultrasound based model of the anatomy.

Example procedures include but are not limited to:

{1}------------------------------------------------

Cranial Procedures:

Cranial biopsies Tumor resections Craniotomies/ Craniectomies Skull base procedures Thalamotomies/Pallidotomies

ENT Procedures:

Transphenoidal procedures Intranasal procedures Sinus procedures, such as Maximillary antrostomies, Ethmoidectomies, Spheno-idotomies / Sphenoid explorations, Turbinate resections and Frontal sinusotomies

Device Description

The tracking system consists of two infrared light sources and infrared cameras. Around each camera lens is an array of infrared LED's, which flood the field of view with infrared light. The infrared light is reflected by retro-reflective material (reflects light back to the light source) to the two cameras. This tracking principle does not require electrical cords on the reflecting targets and is therefore called passive tracking system.

Software

The tracking system sends the targets 2D and 3D position to the navigation workstation, The navigation software uses this information considering known geometric information for tracking the 3D position of probes and other surgical tools with attached retro-reflective marker arrays.

To link the virtual diagnostic image space within the navigation system to the surgical environment, the surgeon selects points on the patient using a tracked pointer probe. The selected points are stored and interpreted by the computer and related to corresponding points extracted from the diagnostic image data sets.

A different option to register the patient anatomy to the virtual image space is provided by means of a laser scanning device. With this laser device the surface of the patients head is scanned meanwhile the IR camera system picks up the laser reflections on the patients skin. By creating a virtual surface model out of the 3D coordinates of these laser points the software matches patient data set and the patient position inside the operation poor.

Another contactless registration method for MR image data is provided by a localizer geometry of MR markers, which is - by fixed relation to the patient and the reference array and by automatic registration of the markers - a direct link to the virtual inage space. In combination with the integration of data transfer functionalities this registration method is preferred for intra-operative MR data use.

The device visualizes patient data including the option to overlay multiple data sets, outlined structures and trajectories. The area of interest is displayed in the virtual computer image space in 2D- and 3D-representations.

{2}------------------------------------------------

For the localization of any area or structure in the patient's body a pointer tool is used or any other surgical instrument with attached retro-reflective marker arrays. A special device is available to precisely register any surgical instrument for navigation.

Surgical microscopes are integrated similarly as a virtual pointer tool by a mounted marker array and a software interface. With image injection modules and video display a close cooperation of navigation system and microscope is achieved. Other intraoperative image sources like ultrasound transducers and endoscopes are tracked and integrated similarly and can be controlled within the software to be displayed on an external display device for the purpose of non-diagnostic image information overview.

For sending requests and commands to external software and computers via network, e.q. for controlling the content of the external display device, a general communication interface is integrated into the navigation software.

Hardware

The VectorVision hardware platforms consist of electronic hardware combined in different housings which allow to adapt to the respective needs in certain OR settings. There are infrared cameras and a touch-screen, signal transmission cables, the navigation workstation itself and cable interfaces to external devices (e.g. microscopes). Currently there are 3 platforms available: VectorVision?, VectorVision Compact and VectorVision Sky. With the VectorVision Sky ceiling mounted articulated arms carry camera and touchscreen. The VectorVision Sky can be prepared for use in magnet-resonance environments with shielded RF cage e.g. by providing optical signal transmission. Interfacing external devices such as a microscope and/or a surgical endoscope is realized by interface elements in a wall panel box.

VectorVision does not contain implants but provides a system for accurate implant placement.

Substantial equivalence

VectorVision Cranial / ENT has been verified and validated according to BrainLAB's procedures for product design and development. The validation proves the safety and effectiveness of the system. The information provided by BrainLAB in this 510/ld application was found to be substantially equivalent with the predicate device VectorVision2 (K983831) and VectorVision Cranial / ENT / Spine (K003589).

{3}------------------------------------------------

Part 3 Combination Product Algorithm (Revised March 12, 2003)

Category NumberType of Part 3 Combination Product
NNot a Part 3 Combination Product
1Convenience Kit or Co-Package
2Prefilled Drug Delivery Device/System (syringe, patch, etc.)
3Prefilled Biologic Delivery Device/System (syringe, patch, etc.)
4Device Coated/Impregnated/Otherwise Combined with Drug
5Device Coated or Otherwise Combined with Biologic
6Drug/Biologic Combination
7Separate Products Requiring Cross Labeling
8Possible Combination Based on Cross Labeling of SeparateProducts (Temporary Code)
9Other Type of Part 3 Combination Product (e.g.,Drug/Device/Biologic Product)

Quick Reference Table1 -- Part 3 Combination Product Categories

Note: The above categories are intended to be mutually exclusive. If a product meets the definition of more than one category, select the category that you believe best describes the regulatory issues associated with the combination product.

Overview: A 21 CFR Part 3 combination product is a product comprised of components usually regulated under different authorities. It may be a drug combined with a device, a biologic combined with a device, or a drug combined with a biologic. Cells or tissues that are not eligible for regulation solely as cells or tissues because they are combined with a drug or a device (except for a sterilizing, preserving, or storage agent) may also be combination products. Discuss with your Center's product jurisdiction officer.

Combination products include those where the components are":

  • Physically or chemically combined OR .
  • . Separate but provided/packaged as a unit OR

1 Category descriptions and examples follow.

2 See 21 CFR § 3.2(e) for complete definition. [will link to definition on OCP website]

{4}------------------------------------------------

Image /page/4/Picture/1 description: The image shows the logo for the Department of Health & Human Services - USA. The logo is circular and contains the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is an abstract symbol that resembles an eagle or bird with three wing-like shapes above three wavy lines.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

FEB 1 7 2004

Mr. Ranier Birkenbach BrainLAB AG Ammerthalstrasse 8 85551 Heimstetten Germany

Rc: K023651

Trade/Device Name: VectorVision Cranial/ENT Regulation Number: 21 CFR 882.4560 Regulation Name: Stereotaxic instrument Regulatory Class: II Product Code: HAW Dated: November 17, 2004 Received: November 19, 2004

Dear Mr. Birkenbach:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination docs not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CHR 1000-1050.

{5}------------------------------------------------

Page 2 - Mr. Ranier Birkenbach

This letter will allow you to begin marketing your device as described in your Section 510/k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4659. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html

Sincerely vours.

for Mark N. Mellema

Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{6}------------------------------------------------

Indications for Use

510(k) Number (if known): K023651

Device Name:

VectorVision Cranial/ENT

Indications For Use:

VectorVision Cranial/ENT is intended to be an intraoperative image guided localization system to enable minimally invasive surgery. It links a freehand probe, tracked by a passive marker sensor system to virtual computer image space on patient image data being processed by the VectorVision workstation.

The system is indicated for any medical condition in which the use of stereotactic surgery may be appropriate and where a reference to a rigid anatomical structure, such as the skull, a long bone, or vertebra, can be identified relative to a CT, CTA, X-ray, MR, MRA and ultrasound based model of the anatomy,

Example procedures include but are not limited to:

Cranial Procedures: Cranial biopsies Tumor resections Craniotomies/ Craniectomies Skull base procedures Thalamotomies/Pallidotomies

ENT Procedures: Transphenoidal procedures Intranasal procedures Sinus procedures, such as Maximillary antrostomies, Ethmoidectomies / Sphenoid explorations, Turbinate resections and Frontal sinusotomies

Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR

Over-The-Counter Use (21 CFR 807 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRA, Office of Device Evaluation (ODE)

al. Restorative, and Neurological Devices

Page 1 of 1

510(k) Number K02365

§ 882.4560 Stereotaxic instrument.

(a)
Identification. A stereotaxic instrument is a device consisting of a rigid frame with a calibrated guide mechanism for precisely positioning probes or other devices within a patient's brain, spinal cord, or other part of the nervous system.(b)
Classification. Class II (performance standards).